Welcome to our dedicated page for Reflect Scientfc news (Ticker: RSCF), a resource for investors and traders seeking the latest updates and insights on Reflect Scientfc stock.
Reflect Scientific, Inc. (RSCF) delivers innovative cryogenic cooling solutions for healthcare, biotechnology, and industrial markets. This news hub provides investors and industry professionals with essential updates on corporate developments and technological advancements.
Access official press releases covering product innovations, financial results, strategic partnerships, and regulatory milestones. Our curated collection ensures timely updates on RSCF's low-temperature freezer systems, refrigerated containers, and specialized chillers serving critical applications from pharmaceutical storage to aerospace manufacturing.
Key content includes earnings announcements, technology patents, executive leadership updates, and industry-specific applications of cryogenic solutions. Bookmark this page for centralized access to verified information about RSCF's progress in advancing temperature control systems for sensitive materials.
Reflect Scientific, Inc. (RSCF) reported a remarkable 4,067% increase in chiller sales for the first quarter of 2022, totaling $244,000, up from $6,000 in the same period in 2021. This growth follows the easing of COVID-19 related shutdowns. The second quarter also showcased strong performance, achieving $291,000 in sales. CEO Mr. Boyce highlighted significant product improvements based on customer feedback, contributing to the surge in demand for their Cryometrix solvent chillers, widely used in pharmaceutical and biotech industries.
Reflect Scientific, Inc. (RSCF) reported its annual 10K financial results, showing a slight revenue increase of 0.8% to $2.81 million for 2021. Gross margin improved to 69%, up from 62% the previous year, attributed to reduced production costs. The net income rose to $939,065 compared to $660,115 in 2020. The company also enhanced its cash position, with $1.47 million in cash and equivalents, compared to $643,000 in 2020. Reflect Scientific has returned to fully reporting status with the SEC and uplisted to OTCQB for better access to capital.
Reflect Scientific, Inc. (RSCF), a leader in biotechnology and transportation technologies, reported strong sales and profitability, driven by robust demand for blast freezers and chillers. The company successfully uplisted to the OTC QB, enhancing visibility and investor confidence. With a pending patent for HFC-free refrigeration solutions, Reflect Scientific aims to support green initiatives amid federal efforts to reduce greenhouse gas emissions. Their innovative technology also targets cold chain management and applications in diverse industries, including Bitcoin mining.
Reflect Scientific, Inc. (OTCQB: RSCF) reported its third-quarter financial results for 2021, highlighting a revenue increase to $716,145 compared to $610,085 the previous year. Gross profit also rose to $473,802 from $357,973 in Q3 2020, demonstrating improved margins in their cryogenic product line. The company's operating income stood at $159,889, indicating continued profitability despite market uncertainties. CEO Mr. Boyce emphasized the firm’s resilience in delivering products and maintaining positive financial outcomes.
Reflect Scientific, Inc. (RSCF) announced its successful up-listing to OTCQB effective October 28, 2021. This move aims to enhance investor access and support the company’s growth strategy. The OTCQB operates under the OTC Markets Group and is tailored for emerging companies, requiring current reporting and management certification. This listing is recognized by the SEC and allows for greater public information to aid investor analysis. Reflect Scientific develops innovative cryogenic cooling technologies for multiple industries, including biotechnology and pharmaceuticals.
Reflect Scientific, Inc. (Symbol: RSCF) announced its uplisting to the OTCQB Venture Market, enhancing its capital access and market visibility. CEO Kim Boyce emphasized that this strategic move aligns with the company’s growth plans in the cryogenic refrigeration sector. Reflect Scientific specializes in innovative cryogenic cooling technologies, primarily for the biotechnology and pharmaceutical industries. The uplisting is expected to facilitate future growth and acquisitions as the company expands its presence in the market.
Reflect Scientific, Inc. (RSCF) reports over $500K in orders for Cryometrix cryogenic cooling products in the last 30 days, marking a significant increase since pandemic restrictions eased. The Cryometrix line includes ultra-cold freezers and solvent chillers used in bio-pharmaceutical industries. CEO Kim Boyce stated the company has completed its third profitable quarter this year, driven by a notable uptick in demand for their products. This reflects the recovery trends within the biotech sector as restrictions lift.
Reflect Scientific, Inc. (RSCF) has expanded its distribution for the Cryometrix liquid nitrogen-enabled solvent chillers by signing agreements with two major cannabinoid extraction equipment companies. This partnership enhances market exposure for Cryometrix chillers, aimed at improving extraction efficiency and speed. Orders for these chillers have already been placed. CEO Kim Boyce highlighted the growing cannabis extraction market, projected to reach a value of $7.3 billion in 2019 with a CAGR of over 16%, emphasizing the chillers' role in increasing throughput and product quality.
Reflect Scientific, Inc. (RSCF) reported strong financial results for Q2 2021. Revenue rose to $707,133, up 40.5% from $502,906 in Q2 2020. Gross profit increased to $471,954, reflecting effective cost management as operating expenses decreased to $301,173 from $405,811 year-over-year. The company is focused on R&D, introducing new cryogenic products while maintaining a healthy cash position. Challenges from pandemic-related shipping issues have been managed effectively, and the overall performance has been positively received by the CEO.
Reflect Scientific, Inc. (RSCF) announces signs of market improvement for its Cryometrix solvent chillers used in cannabis processing. Following pandemic-related downturns, the CBD market is rebounding, with forecasts indicating a CAGR of 21.2% from 2021 to 2028. CEO Kim Boyce noted a resurgence in orders as the market recovers. The patented L-80 MAX and LITE chillers efficiently extract cannabinoids and terpenes from raw cannabis while discarding unwanted materials. The company develops innovative cryogenic cooling technologies targeted at various industries, including biotechnology and pharmaceuticals.